Data were anonymously and retrospectively collected from patients records using the REDCap software
About this article Cite this article Qian, Y., Xia, F., Zuo, Y
Although there are many ongoing large CVD outcome trials of GLP-1 RA treatment (Table 1), more simultaneous investigation of the causal relationship between GLP-1 RA administration and useful surrogate measures of CVD, including carotid IMT, would help us understand the potential mechanisms through which GLP-1 RAs may result in favorable cardiovascular outcomes in patients with T2D
Routine thyroid screening is not recommended, but patients should report neck lumps, persistent hoarseness, or swallowing difficulties promptly
Determining the effectiveness of semaglutide involves monitoring specific health parameters